|
|
- CAS号:
- 2169919-21-3
- 英文名:
- SNDX-5613
- 英文别名:
- SNDX-5613;Revumenib;SNDX-5613 SNDX5613;acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid;N-Ethyl-2-((4-(7-((trans-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide;Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
- 中文名:
- SNDX-5613
- 中文别名:
- 化合物SNDX-5613;N-乙基-2-((4-(7-((反式-4-(乙基磺酰胺基)环己基)甲基)-2,7-二氮杂螺[3.5]壬烷-2-基)嘧啶-5-基)氧基)-5-氟-N-异丙基苯甲酰胺;N- 乙基- 2- [[4- [7- [[[反式- 4- [(乙磺酰基) 氨基] 环己基] 甲基] - 2, 7- 二氮杂螺[ 3.5] 非- 2- 基] - 5- 嘧啶基] 氧基] - 5- 氟- N- (1- 甲基乙基) 苯甲酰胺
- CBNumber:
- CB47244410
- 分子式:
- C32H47FN6O4S
- 分子量:
- 630.82
- MOL File:
- 2169919-21-3.mol
|
|
|